Doctor checking patient's lymph nodes in office
JackF / iStock

A Towson University–led study reveals wide geographic variation in caregiver-reported US clinician recommendations to adolescents regarding the human papillomavirus (HPV) vaccine.

For the study, published last week in Cancer Causes & Control, the researchers modeled data from the 2023 National Immunization Survey–Teen on state-level variations in clinician HPV-vaccination guidance for adolescents aged 13 to 17, with California as the reference state.

The HPV vaccine prevents viral infection that can cause different types of cancer, including cervical cancer. 

“Adolescents aged 13–17 years represent a particularly important population for examining provider recommendations because they remain eligible for routine and catch-up HPV vaccination,” the authors wrote.“Understanding state-level variation may help identify local patterns that are masked by broader regional analyses and inform more targeted public health policies and interventions.”

Lack of doctor training, time constraints

HPV recommendations varied widely by state. For example, recommendations were less likely in Arkansas (adjusted odds ratio [aOR], 0.56), Georgia (aOR, 0.49), and Mississippi (aOR, 0.42), although the confidence intervals of all findings were wide, indicating imprecision.

The findings help determine which states contribute to the region’s overall low rates and pinpoints where additional public health efforts are most needed to improve the recommendation of HPV vaccine.

“This finding may, to some extent, explain the lower vaccination rates observed in these states, as health care provider recommendation is a strong driver of vaccine uptake,” the researchers wrote.

The odds of HPV recommendation delivery were higher in New Hampshire (aOR, 2.40). Wider variation was seen in the South than in the Northeast and Midwest. For instance, the rate of recommendation non-receipt was 16% in Maryland and 41% in Mississippi.

Some Northeastern and Western states had a higher likelihood of HPV-vaccine recommendation receipt (eg, only 12% of respondents in New Hampshire and 19% in Colorado reported not receiving a recommendation).

The lower rates of recommendation in the South may be partially attributed to barriers such as a lack of physician training, time constraints, and a paucity of effective tools and patient education materials, the researchers said.

“The findings help determine which states contribute to the region’s overall low rates and pinpoints where additional public health efforts are most needed to improve the recommendation of HPV vaccine,” they wrote.



Source link